COVID-19 antibody treatments capped amid shortage

HONOLULU — Hawaii health care providers are receiving only half the number of monoclonal antibody treatments for COVID-19 that they requested amid a shortage of the drugs.

Start Free AccountGet access to 7 premium stories every month for FREE!
Already a Subscriber?Current print subscriber? Activate your complimentary Digital account.
Subscribe NowChoose a package that suits your preferences.